The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Any hepatic decompensation significantly impairs prognosis in cirrhotic patients.
“Apart from treating esophageal varices, patients with NAFLD‐associated ACLD should be classified as either being “compensated‐” or “decompensated”, since any hepatic decompensation significantly impairs prognosis in cirrhotic patients [101, 102].”
From Current treatment of non‐alcoholic fatty liver disease (2022) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical Prediction Rules: Applications and Methodological Standards
Wasson, J. H., Sox, H. C., Neff, R. K., & Goldman, L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509263131306 · Cited by 1,357
Flagged first, then by citations
Research works printed but not linked: 148
- Child, 1964, Surgery and portal hypertension, Major Probl Clin Surg, 1, 1
- Kamath, 2001, A model to predict survival in patients with end-stage liver disease, Hepatology, 33, 464, 10.1053/jhep.2001.22172 · DOI
- Durand, 2005, Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD, J Hepatol, 42, S100, 10.1016/j.jhep.2004.11.015 · DOI
- D'Amico G, Garcia–Tsao G, Abraldes J, Ginès P, Kim WR, Schepis F, et al. Prognostic indicators in cirrhosis. In: de Franchis R, editor. Portal Hypertension IV. Proceedings of the Fourth Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Blackwell, 2005.
- Saunders, 1981, A 20-year prospective study of cirrhosis, Br Med J, 282, 263, 10.1136/bmj.282.6260.263 · DOI
- Gines, 1987, Compensated cirrhosis: natural history and prognosis, Hepatology, 7, 122, 10.1002/hep.1840070124 · DOI
- D'Amico, 1986, Survival and prognostic indicators in compensated and decompensated cirrhosis, Dig Dis Sci, 31, 468, 10.1007/BF01320309 · DOI
- D'Amico, 2001, The incidence of esophageal varices in cirrhosis, Gastroenterology, 120, A2, 10.1016/S0016-5085(08)80011-X · DOI
- de Franchis, 2005, Evolving consensus in portal hypertension report of the baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension, J Hepatol, 43, 167, 10.1016/j.jhep.2005.05.009 · DOI
- Infante-Rivard, 1987, Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics, Hepatology, 7, 660, 10.1002/hep.1840070408 · DOI
- Chianciano consensus conference on prognostic studies in hepatology. Ital J Gastroenterol Hepatol 1998; 30: 580-3.
- Oxford Centre for Evidence Based Medicine. Levels of Evidence and Grades of Recommendation; 2001 [Ref Type: Internet Communication].
- Wells, 1990, A comparison of multivariable mathematical methods for predicting survival–III. Accuracy of predictions in generating and challenge sets, J Clin Epidemiol, 43, 361, 10.1016/0895-4356(90)90122-6 · DOI
- Heckerling, 1992, Reproducibility of predictor variables from a validated clinical rule, Med Decis Making, 12, 280, 10.1177/0272989X9201200406 · DOI
- Buligescu, 1987, Study of the prognosis factors in liver cirrhosis, Med Interne, 25, 157
- Casaril, 1987, Prognostic score in liver cirrhosis developed using the Cox's proportional hazard regression model, Ric Clin Lab, 17, 67, 10.1007/BF02909391 · DOI
- Adler, 1992, A Pugh score of 8 adequately selects patients with parenchymal cirrhosis for liver transplantation, Transpl Int, 5, S175, 10.1111/tri.1992.5.s1.175 · DOI
- Altman, 1995, Survival after a first episode of spontaneous bacterial peritonitis. Prognosis of potential candidates for orthotopic liver transplantation, J Gastroenterol Hepatol, 10, 47, 10.1111/j.1440-1746.1995.tb01046.x · DOI
- Habib, 2005, High-density lipoprotein cholesterol as an indicator of liver function and prognosis in noncholestatic cirrhotics, Clin Gastroenterol Hepatol, 3, 286, 10.1016/S1542-3565(04)00622-6 · DOI
- Ekindjian, 1981, Multivariate analysis of clinical and biological data in cirrhotic patients: application to prognosis, Eur J Clin Invest, 11, 213, 10.1111/j.1365-2362.1981.tb01843.x · DOI
- Rossi, 1986, Grading scores and survivorship functions in liver cirrhosis: a comparative statistical analysis of various predictive models, Hepatogastroenterology, 33, 240
- Pomier-Layrargues, 1988, Prognostic value of indocyanine green and lidocaine kinetics for survival and chronic hepatic encephalopathy in cirrhotic patients following elective end-to-side portacaval shunt, Hepatology, 8, 1506, 10.1002/hep.1840080607 · DOI
- Thomsen, 1994, Optimized analysis of recurrent bleeding and death in patients with cirrhosis and esophageal varices. Copenhagen esophageal varices sclerotherapy project, J Hepatol, 21, 367, 10.1016/S0168-8278(05)80315-0 · DOI
- Shiomi, 1995, Clinical usefulness of evaluation of portal circulation by per rectal portal scintigraphy with technetium-99m pertechnetate, Am J Gastroenterol, 90, 460
- Borroni, 2000, Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients, Dig Liver Dis, 32, 605, 10.1016/S1590-8658(00)80844-0 · DOI
- Zhao, 2002, Prognosis of hepatic cirrhosis patients with esophageal or gastric variceal hemorrhage: multivariate analysis, Hepatobiliary Pancreat Dis Int, 1, 416
- Degre, 2004, Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation, Transpl Int, 17, 31, 10.1007/s00147-003-0655-6 · DOI
- Orrego, 1983, Assessment of prognostic factors in alcoholic liver disease: toward a global quantitative expression of severity, Hepatology, 3, 896, 10.1002/hep.1840030602 · DOI
- Schlichting, 1983, Prognostic factors in cirrhosis identified by Cox's regression model, Hepatology, 3, 889, 10.1002/hep.1840030601 · DOI
- Christensen, 1984, Prognostic value of Child-Turcotte criteria in medically treated cirrhosis, Hepatology, 4, 430, 10.1002/hep.1840040313 · DOI
- Poynard, 1984, Prognostic value of total serum bilirubin/gamma-glutamyl transpeptidase ratio in cirrhotic patients, Hepatology, 4, 324, 10.1002/hep.1840040224 · DOI
- Milani, 1985, Prognostic significance of clinical and laboratory parameters in liver cirrhosis. A multivariate statistical approach, Hepatogastroenterology, 32, 270
- Naveau, 1985, Prognostic value of serum fibronectin concentration in alcoholic cirrhotic patients, Hepatology, 5, 819, 10.1002/hep.1840050518 · DOI
- Christensen, 1986, Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables, Scand J Gastroenterol, 21, 163, 10.3109/00365528609034642 · DOI
- Mannes, 1986, Prognostic significance of serum bile acids in cirrhosis, Hepatology, 6, 50, 10.1002/hep.1840060110 · DOI
- Villeneuve, 1986, Prognostic value of the aminopyrine breath test in cirrhotic patients, Hepatology, 6, 928, 10.1002/hep.1840060520 · DOI
- Gines, 1987, Compensated cirrhosis: natural history and prognostic factors, Hepatology, 7, 122, 10.1002/hep.1840070124 · DOI
- Tanaka, 1987, Follow-up study of 582 liver cirrhosis patients for 26 years in Japan, Liver, 7, 316, 10.1111/j.1600-0676.1987.tb00362.x · DOI
- Tsuji, 1987, Prediction of the prognosis of liver cirrhosis in Japanese using Cox's proportional hazard model, Gastroenterol Jpn, 22, 599, 10.1007/BF02776720 · DOI
- Llach, 1988, Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites, Gastroenterology, 94, 482, 10.1016/0016-5085(88)90441-6 · DOI
- Gluud, 1988, Tthe copenhagen study group for liver disease. Prognostic indicators in alcoholic cirrhotic men, Hepatology, 8, 222, 10.1002/hep.1840080205 · DOI
- Tage-Jensen, 1988, Plasma catecholamine level and portal venous pressure as guides to prognosis in patients with cirrhosis, J Hepatol, 6, 350, 10.1016/S0168-8278(88)80053-9 · DOI
- Albers, 1989, Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis, Scand J Gastroenterol, 24, 269, 10.3109/00365528909093045 · DOI
- Christensen, 1989, Prognosis after the first episode of gastrointestinal bleeding or coma in cirrhosis. Survival and prognostic factors, Scand J Gastroenterol, 24, 999, 10.3109/00365528909089247 · DOI
- Wang, 1989, An analysis of prognostic factors in cirrhosis, Chin Med J (Engl), 102, 266
- Merkel, 1989, Prognostic indicators of survival in patients with cirrhosis and esophageal varices, without previous bleeding, Am J Gastroenterol, 84, 717
- Merkel, 1989, Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosis, J Hepatol, 9, 16, 10.1016/0168-8278(89)90070-6 · DOI
- Adler, 1990, Factors influencing survival at one year in patients with nonbiliary hepatic parenchymal cirrhosis, Dig Dis Sci, 35, 1, 10.1007/BF01537214 · DOI
- Tameda, 1990, Prognostic value of peritoneoscopic findings in cirrhosis of the liver, Gastrointest Endosc, 36, 34, 10.1016/S0016-5107(90)70919-4 · DOI
- Bayerdorffer, 1991, Predictive value of serum procollagen-III-peptide for the survival of patients with cirrhosis, J Hepatol, 13, 298, 10.1016/0168-8278(91)90072-J · DOI
- Finucci, 1991, Evaluation of splanchnic angiography as a prognostic index of survival in patients with cirrhosis, Scand J Gastroenterol, 26, 951, 10.3109/00365529108996248 · DOI
- Kleber, 1991, Prediction of variceal hemorrhage in cirrhosis: a prospective follow-up study, Gastroenterology, 100, 1332, 10.1016/0016-5085(91)70021-O · DOI
- Merkel, 1991, Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score, Dig Dis Sci, 36, 1197, 10.1007/BF01307508 · DOI
- Oellerich, 1991, Predictors of one-year pretransplant survival in patients with cirrhosis, Hepatology, 14, 1029, 10.1002/hep.1840140614 · DOI
- Zoli, 1991, Prognostic indicators in compensated cirrhosis, Am J Gastroenterol, 86, 1508
- de Jongh, 1992, Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver, Gastroenterology, 103, 1630, 10.1016/0016-5085(92)91188-A · DOI
- Ferro, 1992, 1-year survey of patients with advanced liver cirrhosis. Prognostic value of clinical and laboratory indexes identified by the Cox regression model, Scand J Gastroenterol, 27, 852, 10.3109/00365529209000153 · DOI
- McCormick, 1992, The effects of alcohol use on rebleeding and mortality in patients with alcoholic cirrhosis following variceal haemorrhage, J Hepatol, 14, 99, 10.1016/0168-8278(92)90137-E · DOI
- Merkel, 1992, Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices, Gastroenterology, 102, 973, 10.1016/0016-5085(92)90185-2 · DOI
- Merkel, 1992, Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis, Gut, 33, 836, 10.1136/gut.33.6.836 · DOI
- Abad-Lacruz, 1993, Routine tests of renal function, alcoholism, and nutrition improve the prognostic accuracy of Child-Pugh score in nonbleeding advanced cirrhotics, Am J Gastroenterol, 88, 382
- Cabre, 1993, The relationship of plasma polyunsaturated fatty acid deficiency with survival in advanced liver cirrhosis: multivariate analysis, Am J Gastroenterol, 88, 718
- Oellerich, 1993, Assessment of prognosis in transplant candidates by use of the Pugh-MEGX score, Transplant Proc, 25, 1116
- Salerno, 1993, Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients, Am J Gastroenterol, 88, 514
- Zoli, 1993, Prognostic significance of portal hemodynamics in patients with compensated cirrhosis, J Hepatol, 17, 56, 10.1016/S0168-8278(05)80521-5 · DOI
- Arrigoni, 1994, Monoethylglicinexylidide test: a prognostic indicator of survival in cirrhosis, Hepatology, 20, 383, 10.1002/hep.1840200218 · DOI
- Bianchi, 1994, Prognostic significance of diabetes in patients with cirrhosis, Hepatology, 20, 119
- Maroto, 1994, Diagnosis of functional kidney failure of cirrhosis with Doppler sonography: prognostic value of resistive index, Hepatology, 20, 839, 10.1002/hep.1840200411 · DOI
- Moller, 1994, Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding, J Hepatol, 21, 940, 10.1016/S0168-8278(05)80599-9 · DOI
- Realdi, 1994, Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The investigators of the European concerted action on Viral Hepatitis (EUROHEP), J Hepatol, 21, 656, 10.1016/S0168-8278(94)80115-0 · DOI
- Urbain, 1994, Prognostic value of thallium-201 per rectum scintigraphy in alcoholic cirrhosis, J Nucl Med, 35, 832
- Sugimura, 1994, Long-term prognosis and prognostic factors of liver cirrhosis in the 1980s, J Gastroenterol Hepatol, 9, 154, 10.1111/j.1440-1746.1994.tb01236.x · DOI
- Homann, 1995, Plasma calprotectin: a new prognostic marker of survival in alcohol-induced cirrhosis, Hepatology, 21, 979, 10.1002/hep.1840210415 · DOI
- Ohta, 1995, Prognostic significance of hepatic vein waveform by Doppler ultrasonography in cirrhotic patients with portal hypertension, Am J Gastroenterol, 90, 1853
- Urbain, 1995, Aminopyrine breath test improves long-term prognostic evaluation in patients with alcoholic cirrhosis in Child classes A and B, J Hepatol, 22, 179, 10.1016/0168-8278(95)80426-9 · DOI
- Violi, 1995, Prognostic value of clotting and fibrinolytic systems in a follow-up of 165 liver cirrhotic patients. CALC Group, Hepatology, 22, 96
- Merkel, 1996, The course of galactose elimination capacity in patients with alcoholic cirrhosis: possible use as a surrogate marker for death, Hepatology, 24, 820, 10.1002/hep.510240412 · DOI
- Merli, 1996, Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi), Hepatology, 23, 1041, 10.1002/hep.510230516 · DOI
- Salerno, 1996, J Hepatol, 25, 474, 10.1016/S0168-8278(96)80206-6 · DOI
- Vorobioff, 1996, Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study, Gastroenterology, 111, 701, 10.1053/gast.1996.v111.pm8780575 · DOI
- Adler, 1997, Prognostic evaluation of patients with parenchymal cirrhosis. Proposal of a new simple score, J Hepatol, 26, 642, 10.1016/S0168-8278(97)80431-X · DOI
- Chan, 1997, Prognostic value of plasma endotoxin levels in patients with cirrhosis, Scand J Gastroenterol, 32, 942, 10.3109/00365529709011206 · DOI · Paper page
- Fattovich, 1997, Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients, Gastroenterology, 112, 463, 10.1053/gast.1997.v112.pm9024300 · DOI
- Gentilini, 1997, Long course and prognostic factors of virus-induced cirrhosis of the liver, Am J Gastroenterol, 92, 66
- Homann, 1997, Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality, Gut, 40, 544, 10.1136/gut.40.4.544 · DOI
- Jover, 1997, Salivary caffeine clearance predicts survival in patients with liver cirrhosis, Am J Gastroenterol, 92, 1905
- Magliocchetti, 1997, Prognostic factors for long-term survival in cirrhotic patients after the first episode of liver decompensation, Ital J Gastroenterol Hepatol, 29, 38
- Caregaro, 1998, Nutritional and prognostic significance of serum hypothyroxinemia in hospitalized patients with liver cirrhosis, J Hepatol, 28, 115, 10.1016/S0168-8278(98)80210-9 · DOI
- Merkel, 1998, Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates, Ital J Gastroenterol Hepatol, 30, 276
- Serfaty, 1998, Determinants of outcome of compensated hepatitis C virus-related cirrhosis, Hepatology, 27, 1435, 10.1002/hep.510270535 · DOI
- Stanley, 1998, Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis, Quaterly J Med, 91, 19
- Amodio, 1999, Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests, Hepatology, 29, 1662, 10.1002/hep.510290619 · DOI
- Bustamante, 1999, Prognostic significance of hepatic encephalopathy in patients with cirrhosis, J Hepatol, 30, 890, 10.1016/S0168-8278(99)80144-5 · DOI
- Hu, 1999, The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States, Hepatology, 29, 1311, 10.1002/hep.510290424 · DOI
- Macias-Rodriguez, 1999, Prognostic usefulness of ultrasonographic signs of portal hypertension in patients with child-pugh stage a liver cirrhosis, Am J Gastroenterol, 94, 3595, 10.1111/j.1572-0241.1999.01548.x · DOI
- Patch, 1999, Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding, Gut, 44, 264, 10.1136/gut.44.2.264 · DOI
- Testa, 1999, Can the MEGX test and serum bile acids improve the prognostic ability of Child-Pugh's score in liver cirrhosis?, Eur J Gastroenterol Hepatol, 11, 559, 10.1097/00042737-199905000-00016 · DOI
- Degos, 2000, Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death, Gut, 47, 131, 10.1136/gut.47.1.131 · DOI
- del Olmo, 2000, Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis, J Hepatol, 32, 19, 10.1016/S0168-8278(01)68827-5 · DOI
- Fattovich, 2000, Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European concerted action on Viral Hepatitis (Eurohep), Gut, 46, 420, 10.1136/gut.46.3.420 · DOI
- Ganne-Carrie, 2000, Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study, Gut, 46, 277, 10.1136/gut.46.2.277 · DOI
- Guechot, 2000, Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis, J Hepatol, 32, 447, 10.1016/S0168-8278(00)80396-7 · DOI
- Alberino, 2001, Nutrition and survival in patients with liver cirrhosis, Nutrition, 17, 445, 10.1016/S0899-9007(01)00521-4 · DOI
- Amodio, 2001, Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients, J Hepatol, 35, 37, 10.1016/S0168-8278(01)00129-5 · DOI
- Fernandez-Esparrach, 2001, A prognostic model for predicting survival in cirrhosis with ascites, J Hepatol, 34, 46, 10.1016/S0168-8278(00)00011-8 · DOI
- Fattovich, 2001, Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe, J Viral Hepat, 8, 206, 10.1046/j.1365-2893.2001.00291.x · DOI
- Franca, 2001, Long-term prognosis of cirrhosis after spontaneous bacterial peritonitis treated with ceftriaxone, J Clin Gastroenterol, 33, 295, 10.1097/00004836-200110000-00007 · DOI
- Puthumana, 2001, Prolonged QTc interval and its relationship to autonomic cardiovascular reflexes in patients with cirrhosis, J Hepatol, 35, 733, 10.1016/S0168-8278(01)00217-3 · DOI
- Deltenre, 2002, Lack of prognostic usefulness of hepatic venous pressures and hemodynamic values in a select group of patients with severe alcoholic cirrhosis, Am J Gastroenterol, 97, 1187, 10.1111/j.1572-0241.2002.05702.x · DOI
- Fattovich, 2002, Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients, Am J Gastroenterol, 97, 2886, 10.1111/j.1572-0241.2002.07057.x · DOI
- Hui, 2002, Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation, J Clin Gastroenterol, 34, 569, 10.1097/00004836-200205000-00018 · DOI
- Porcel, 2002, Dilutional hyponatremia in patients with cirrhosis and ascites, Arch Intern Med, 162, 323, 10.1001/archinte.162.3.323 · DOI
- Selberg, 2002, Norms and correlates of bioimpedance phase angle in healthy human subjects, hospitalized patients, and patients with liver cirrhosis, Eur J Appl Physiol, 86, 509, 10.1007/s00421-001-0570-4 · DOI
- Abraldes, 2003, Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis, Hepatology, 37, 902, 10.1053/jhep.2003.50133 · DOI
- Bal, 2003, Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation, Liver Int, 23, 243, 10.1034/j.1600-0676.2003.00833.x · DOI
- Botta, 2003, MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study, Gut, 52, 134, 10.1136/gut.52.1.134 · DOI
- Hui, 2003, Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C, Hepatology, 38, 420, 10.1053/jhep.2003.50320 · DOI
- Jepsen, 2003, Prognosis of patients with liver cirrhosis and spontaneous bacterial peritonitis, Hepatogastroenterology, 50, 2133
- Korner, 2003, Improvement of prognostic power of the Child-Pugh classification of liver cirrhosis by hyaluronan, J Hepatol, 39, 947, 10.1016/S0168-8278(03)00431-8 · DOI
- Liangpunsakul, 2003, Predictors and implications of severe hypersplenism in patients with cirrhosis, Am J Med Sci, 326, 111, 10.1097/00000441-200309000-00001 · DOI
- Longheval, 2003, Predictive models of short- and long-term survival in patients with nonbiliary cirrhosis, Liver Transpl, 9, 260, 10.1053/jlts.2003.50049 · DOI
- Nidegger, 2003, Cirrhosis and bleeding: the need for very early management, J Hepatol, 39, 509, 10.1016/S0168-8278(03)00322-2 · DOI
- Pessione, 2003, Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence, Liver Int, 23, 45, 10.1034/j.1600-0676.2003.01804.x · DOI
- Schenk, 2003, Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis, Gastroenterology, 125, 1042, 10.1016/S0016-5085(03)01207-1 · DOI
- Serra, 2003, Effect of hepatitis C virus infection and abstinence from alcohol on survival in patients with alcoholic cirrhosis, J Clin Gastroenterol, 36, 170, 10.1097/00004836-200302000-00016 · DOI
- Bell, 2004, Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit, Scand J Gastroenterol, 39, 858, 10.1080/00365520410006350 · DOI
- Gildea, 2004, Predictors of long-term mortality in patients with cirrhosis of the liver admitted to a medical ICU, Chest, 126, 1598, 10.1378/chest.126.5.1598 · DOI
- Giron-Gonzalez, 2004, Implication of inflammation-related cytokines in the natural history of liver cirrhosis, Liver Int, 24, 437, 10.1111/j.1478-3231.2004.0951.x · DOI
- Heuman, 2004, Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death, Hepatology, 40, 802, 10.1002/hep.1840400409 · DOI
- Moreau, 2004, Clinical characteristics and outcome of patients with cirrhosis and refractory ascites, Liver Int, 24, 457, 10.1111/j.1478-3231.2004.0991.x · DOI
- Park, 2004, Clinical significance of variceal hemorrhage in recent years in patients with liver cirrhosis and esophageal varices, J Gastroenterol Hepatol, 19, 1042, 10.1111/j.1440-1746.2004.03383.x · DOI
- Romero-Gomez, 2004, Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy, Hepatology, 39, 939, 10.1002/hep.20152 · DOI
- Yoneyama, 2004, Prognostic index of cirrhotic patients with hepatic encephalopathy with and without hepatocellular carcinoma, Dig Dis Sci, 49, 1174, 10.1023/B:DDAS.0000037808.44897.8a · DOI
- Yoneyama, 2004, Prognostic index of liver cirrhosis with ascites with and without hepatocellular carcinoma, Scand J Gastroenterol, 39, 1272, 10.1080/00365520410008042 · DOI
- Biggins, 2005, Serum sodium predicts mortality in patients listed for liver transplantation, Hepatology, 41, 32, 10.1002/hep.20517 · DOI
- Giron-Gonzalez, 2005, Adhesion molecules as a prognostic marker of liver cirrhosis, Scand J Gastroenterol, 40, 217, 10.1080/00365520510011470 · DOI
- Huo, 2005, Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score, J Hepatol, 42, 826, 10.1016/j.jhep.2005.01.019 · DOI · Paper page
- Kayali, 2005, Hemosiderosis is associated with accelerated decompensation and decreased survival in patients with cirrhosis, Liver Int, 25, 41, 10.1111/j.1478-3231.2005.01022.x · DOI
- Papatheodoridis, 2005, MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis, World J Gastroenterol, 11, 3099, 10.3748/wjg.v11.i20.3099 · DOI
- Pineda, 2005, HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis, Hepatology, 41, 779, 10.1002/hep.20626 · DOI
- Ruf, 2005, Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone, Liver Transpl, 11, 336, 10.1002/lt.20329 · DOI
- Nahon, 2005, Serum albumin and platelet count but not portal pressure are predictive of death in patients with Child-Pugh A hepatitis C virus-related cirrhosis, Gastroenterol Clin Biol, 29, 347, 10.1016/S0399-8320(05)80779-1 · DOI
- Infante-Rivard, 1989, A framework for evaluating and conducting prognostic studies: an application to cirrhosis of the liver, J Clin Epidemiol, 42, 791, 10.1016/0895-4356(89)90077-2 · DOI
- Diamond, 1989, Future imperfect: the limitations of clinical prediction models and the limits of clinical prediction, J Am Coll Cardiol, 14, 12A, 10.1016/0735-1097(89)90157-5 · DOI
- Justice, 1999, Assessing the generalizability of prognostic information, Ann Intern Med, 130, 515, 10.7326/0003-4819-130-6-199903160-00016 · DOI · Paper page
- Harrell, 1985, Regression models for prognostic prediction: advantages, problems, and suggested solutions, Cancer Treat Rep, 69, 1071
- Concato, 1993, The risk of determining risk with multivariable models, Ann Intern Med, 118, 201, 10.7326/0003-4819-118-3-199302010-00009 · DOI
- Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med, in press. · DOI
Cited by
Sorted by citations
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
“In patients with HCC, unlikemost solid tumors, the coexistenceof two life-threatening conditions such as cancer and cirrhosis complicates prognostic assessments [99,128].”
BackgroundLlovet, J. M., Zucman-Rossi, J., Pikarsky, E., Sangro, B., Schwartz, M., Sherman, M., & Gores, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.18 · Cited by 2,531
Garcia‐Tsao, G., Abraldes, J. G., Berzigotti, A., & Bosch, J. (2017) · Hepatology · doi:10.1002/hep.28906 · Cited by 2,154
Self-citationProspective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
Sanyal, A. J., Van Natta, M. L., Clark, J., Neuschwander-Tetri, B. A., Diehl, A., Dasarathy, S., Loomba, R., Chalasani, N., Kowdley, K., Hameed, B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2029349 · Cited by 1,146
ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury
Chalasani, N. P., Hayashi, P. H., Bonkovsky, H. L., Navarro, V. J., Lee, W. M., & Fontana, R. J. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.131 · Cited by 860
Levitt, D., & Levitt, M. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s102819 · Cited by 763
Villanueva, C., Albillos, A., Genescà, J., Garcia-Pagan, J. C., Calleja, J. L., Aracil, C., Bañares, R., Morillas, R. M., Poca, M., Peñas, B., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)31875-0 · Cited by 711
ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
Chalasani, N. P., Maddur, H., Russo, M. W., Wong, R. J., Reddy, K. R., & on behalf of the Practice Parameters Committee of the American College of Gastroenterology (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001259 · Cited by 430
Sanyal, A. J., Harrison, S. A., Ratziu, V., Abdelmalek, M. F., Diehl, A. M., Caldwell, S., Shiffman, M. L., Aguilar Schall, R., Jia, C., McColgan, B., et al. (2019) · Hepatology · doi:10.1002/hep.30664 · Cited by 390
Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis
Berzigotti, A., Garcia-Tsao, G., Bosch, J., Grace, N. D., Burroughs, A. K., Morillas, R., Escorsell, A., Garcia-Pagan, J. C., Patch, D., Matloff, D. S., et al. (2011) · Hepatology · doi:10.1002/hep.24418 · Cited by 325
Self-citationSuk, K. T., Yoon, J., Kim, M. Y., Kim, C. W., Kim, J. K., Park, H., Hwang, S. G., Kim, D. J., Lee, B. S., Lee, S. H., et al. (2016) · Hepatology · doi:10.1002/hep.28693 · Cited by 303
Sandler, N. G., Koh, C., Roque, A., Eccleston, J. L., Siegel, R. B., Demino, M., Kleiner, D. E., Deeks, S. G., Liang, T. J., Heller, T., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.063 · Cited by 307
Underestimation of liver‐related mortality in the United States
Asrani, S. K., Larson, J. J., Yawn, B., Therneau, T. M., & Kim, W. R. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.04.005 · Cited by 311
Current treatment of non‐alcoholic fatty liver disease
Paternostro, R., & Trauner, M. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13531 · Cited by 305
Probiotics Prevent Hepatic Encephalopathy in Patients with Cirrhosis: A Randomized Controlled Trial
Lunia, M. K., Sharma, B. C., Sharma, P., Sachdeva, S., & Srivastava, S. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.11.006 · Cited by 218
Pavlides, M., Banerjee, R., Sellwood, J., Kelly, C. J., Robson, M. D., Booth, J. C., Collier, J., Neubauer, S., & Barnes, E. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.009 · Cited by 212
Safety profile of autologous macrophage therapy for liver cirrhosis
Moroni, F., Dwyer, B. J., Graham, C., Pass, C., Bailey, L., Ritchie, L., Mitchell, D., Glover, A., Laurie, A., Doig, S., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0599-8 · Cited by 202
Cigarette smoking and liver diseases
Marti-Aguado, D., Clemente-Sanchez, A., & Bataller, R. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.01.016 · Cited by 190
Cappuyns, S., Corbett, V., Yarchoan, M., Finn, R. S., & Llovet, J. M. (2024) · JAMA Oncology · doi:10.1001/jamaoncol.2023.2677 · Cited by 167
Cost-effectiveness of hepatocellular carcinoma surveillance: an assessment of benefits and harms
Parikh, N. D., Singal, A. G., Hutton, D. W., & Tapper, E. B. (2020) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000715 · Cited by 163
Kaplan, D. E., Dai, F., Aytaman, A., Baytarian, M., Fox, R., Hunt, K., Knott, A., Pedrosa, M., Pocha, C., Mehta, R., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.010 · Cited by 139
Petta, S., Sebastiani, G., Bugianesi, E., Viganò, M., Wong, V. W.-S., Berzigotti, A., Fracanzani, A. L., Anstee, Q. M., Marra, F., Barbara, M., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.019 · Cited by 140
Beyond scoring: a modern interpretation of disease progression in chronic liver disease
Rosselli, M., MacNaughtan, J., Jalan, R., & Pinzani, M. (2013) · Gut · doi:10.1136/gutjnl-2012-302826 · Cited by 96
LOXL2—A New Target in Antifibrogenic Therapy?
Puente, A., Fortea, J. I., Cabezas, J., Arias Loste, M. T., Iruzubieta, P., Llerena, S., Huelin, P., Fábrega, E., & Crespo, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071634 · Cited by 79
Moctezuma-Velazquez, C., Saffioti, F., Tasayco-Huaman, S., Casu, S., Mason, A., Roccarina, D., Vargas, V., Nilsson, J.-E., Tsochatzis, E., Augustin, S., et al. (2019) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0265-7 · Cited by 78
Liver Fibrosis Leading to Cirrhosis: Basic Mechanisms and Clinical Perspectives
Somnay, K., Wadgaonkar, P., Sridhar, N., Roshni, P., Rao, N., & Wadgaonkar, R. (2024) · Biomedicines · doi:10.3390/biomedicines12102229 · Cited by 70
Rainer, F., Horvath, A., Sandahl, T. D., Leber, B., Schmerboeck, B., Blesl, A., Groselj‐Strele, A., Stauber, R. E., Fickert, P., Stiegler, P., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14474 · Cited by 65
Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial
Brennan, P. N., MacMillan, M., Manship, T., Moroni, F., Glover, A., Troland, D., MacPherson, I., Graham, C., Aird, R., Semple, S. I. K., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03406-8 · Cited by 66
Targeting the Gut–Liver Axis in Cirrhosis: Antibiotics and Non-Selective β-Blockers
Madsen, B. S., Havelund, T., & Krag, A. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0044-1 · Cited by 38
The Human Gut Microbiome in Liver Diseases
Davis, B., & Bajaj, J. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1602763 · Cited by 34
Patient-centered care: Key elements applicable to chronic liver disease
Verma, M., Brahmania, M., Fortune, B. E., Asrani, S. K., Fuchs, M., & Volk, M. L. (2023) · Hepatology · doi:10.1002/hep.32618 · Cited by 24
IGF-I and IGFBP-3 serum levels in patients hospitalized for complications of liver cirrhosis
Ronsoni, M. F., Lazzarotto, C., Fayad, L., Silva, M. C., Nogueira, C. L., Bazzo, M. L., Narciso-Schiavon, J. L., Dantas-Corrêa, E. B., & Schiavon, L. D. L. (2013) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31009-9 · Cited by 20
Ishikawa, N., Watanabe, Y., Maeda, Y., Yoshida, T., Kimura, N., Abe, H., Sakamaki, A., Kamimura, H., Yokoo, T., Kamimura, K., et al. (2025) · Regenerative Therapy · doi:10.1016/j.reth.2025.01.017 · Cited by 6
Metadata
- Authors
- D'Amico, G., Garcia-Tsao, G., & Pagliaro, L.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2006-01
- Volume
- 44
- Issue
- 1
- Pages
- 217-231
- ISSN
- 0168-8278
- Cited by
- 2,687
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review